Continuous glucose monitor sensors now approved to be worn during imaging procedures
Click Here to Manage Email Alerts
Key takeaways:
- The Freestyle Libre 2 and 3 CGM sensors are now approved to be worn during imaging procedures.
- A system integrating the Freestyle Libre 3 with an automated insulin delivery system has been launched.
Abbott announced that the FDA has removed the contraindication for its continuous glucose monitoring sensors to be used during imaging procedures.
The development makes the products (FreeStyle Libre 2 and 3) the only patient-applied CGM sensors approved to be worn during imaging procedures such as X-rays, CT scans and MRIs, according to a press release issued by the company.
The removal of the contraindication means that patients will no longer have to take off and discard their CGM sensors before their wear time has ended, potentially increasing convenience and saving money, the company stated in the release.
“For people with diabetes, especially those using insulin, removing a CGM sensor for long periods can be problematic,” Carol H. Wysham, MD, FACP, FACE, clinical professor of medicine at the University of Washington School of Medicine, section head of the department of diabetes and endocrinology at Rockwood Clinic in Spokane and a Healio | Endocrine Today Editorial Board Member, said in the release. “Previously, patients had to remove their sensors during these procedures, resulting in several hours without critical data, especially if they didn’t have a replacement sensor. The removal of the imaging contraindication from Abbott’s FreeStyle Libre 2 and 3 systems is a big win for patients, allowing them to keep their sensors on and avoid lost data.”
In other CGM news, Beta Bionics announced that its autonomous insulin delivery system (iLet Bionic Pancreas) has become the first autonomous insulin delivery system to be integrated with the FreeStyle Libre 3 Plus CGM sensor, and that the integrated system has been launched.
The CGM sensor’s readings will help the autonomous insulin delivery system calculate insulin doses, according to a press release issued by Beta Bionics.
Reference:
- Beta Bionics announces launch of the iLet Bionic Pancreas with Abbott’s FreeStyle Libre 3 Plus sensor. https://www.betabionics.com/beta-bionics-announces-launch-of-the-ilet-bionic-pancreas-with-abbotts-freestyle-libre-3-plus-sensor. Published Oct. 30, 2024. Accessed Oct. 30, 2024.
Collapse
Read more about
Click Here to Manage Email Alerts